Grace Montepiedra

Biography

Publications

• Impact of in-utero exposure to HIV and latent TB on infant humoral responses.

  Hjelmar KJS, de Armas LR, Goldberg E, Pallikkuth S, Mathad J, Montepiedra G, Gupta A, Pahwa S. Front Immunol 2024

• Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV.

  Montepiedra G, Svensson EM, Wong WK, Hooker AC. CPT Pharmacometrics Syst Pharmacol 2024 02

• Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.

  Gupta A, Singh P, Aaron L, Montepiedra G, Chipato T, Stranix-Chibanda L, Chanaiwa V, Vhembo T, Mutambanengwe M, Masheto G, Raesi M, Bradford S, Golner A, Costello D, Kulkarni V, Shayo A, Kabugho E, Jean-Phillippe P, Chakhtoura N, Sterling TR, Theron G, Weinberg A. Lancet Child Adolesc Health 2023 10

• Predictors of TB disease in HIV-exposed children from Southern Africa.

  Maritz ER, Montepiedra G, Mitchell CD, Madhi SA, Bobat R, Violari A, Hesseling AC, Cotton MF. Int J Tuberc Lung Dis 2023 08 01

• Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial.

  Cherkos AS, LaCourse SM, Enquobahrie DA, Richardson BA, Bradford S, Montepiedra G, Mmbaga BT, Mbengeranwa T, Masheto G, Jean-Phillippe P, Chakhtoura N, Theron G, Weinberg A, Cassim H, Raesi MS, Jean E, Wabwire D, Nematadzira T, Stranix-Chibanda L, Hesseling AC, Aurpibul L, Gupta A, John-Stewart G. EClinicalMedicine 2023